Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1988 Jan;93(1):176–184. doi: 10.1111/j.1476-5381.1988.tb11419.x

Cardiovascular effects of two new calcium antagonists, PY 108-068 and PN 200-110, in conscious spontaneously hypertensive rats.

C Barrès 1, C Cerutti 1, B Morin 1, J Sassard 1
PMCID: PMC1853770  PMID: 2964887

Abstract

1. The acute cardiovascular effects of PY 108-068 and PN 200-110 were studied by means of a computerized analysis of the intra-aortic blood pressure (BP) recorded continuously for 26 h in conscious unrestrained spontaneously hypertensive rats. Both compounds were studied at three doses (50, 100 and 200 micrograms kg-1) and each dose was administered intravenously 5 times (09 h 00 min, 14 h 00 min, 19 h 00 min, 24 h 00 min and 09 h 00 min). Baroreflex sensitivity was measured 1 h following the last injection. 2. The two compounds were found to induce rapid (3 min) and dose-dependent falls in BP. After the first administration, these decreases reached -20% and -35% for systolic BP (SBP) and diastolic BP (DBP) respectively with PY 108-068 (200 micrograms kg-1) and -25% and -45% for SBP and DBP respectively with PN 200-110 (200 micrograms kg-1). 3. The duration of the reduction in BP increased with the dose and was much longer for PN 200-110 (180 min for SBP) than for PY 108-068 (20 min for SBP). 4. A tachycardia was associated with the decrease in BP which did not differ at 200 micrograms kg-1 between PY 108-068 (+ 108 beats min-1) and PN 200-110 (+ 103 beats min-1). Baroreflex sensitivity was not significantly increased by either drug. 5. The 5 repeated injections of PY 108-068 and PN 200-110 evoked similar responses. 6. In conclusion, both compounds exhibited marked hypotensive properties.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
176

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cauvin C., Loutzenhiser R., Van Breemen C. Mechanisms of calcium antagonist-induced vasodilation. Annu Rev Pharmacol Toxicol. 1983;23:373–396. doi: 10.1146/annurev.pa.23.040183.002105. [DOI] [PubMed] [Google Scholar]
  2. Cerutti C., Barres C., Paultre C. Z., Sassard J. Computer analysis of intraarterially recorded blood pressure in conscious unrestrained rats. J Pharmacol Methods. 1985 Jun;13(3):249–260. doi: 10.1016/0160-5402(85)90025-7. [DOI] [PubMed] [Google Scholar]
  3. Fluckiger J. P., Sonnay M., Boillat N., Atkinson J. Attenuation of the baroreceptor reflex by general anesthetic agents in the normotensive rat. Eur J Pharmacol. 1985 Feb 12;109(1):105–109. doi: 10.1016/0014-2999(85)90545-x. [DOI] [PubMed] [Google Scholar]
  4. Hof R. P., Hof A., Neumann P. Effect of PY 108-068, a new calcium antagonist, on general hemodynamics and regional blood flow in anesthetized cats: a comparison with nifedipine. J Cardiovasc Pharmacol. 1982 May-Jun;4(3):352–362. doi: 10.1097/00005344-198205000-00003. [DOI] [PubMed] [Google Scholar]
  5. Hof R. P., Hof A., Scholtysik G., Menninger K. Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol. 1984 May-Jun;6(3):407–416. doi: 10.1097/00005344-198405000-00006. [DOI] [PubMed] [Google Scholar]
  6. Hof R. P., Scholtysik G. Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):176–183. doi: 10.1097/00005344-198303000-00002. [DOI] [PubMed] [Google Scholar]
  7. Hof R. P., Scholtysik G., Loutzenhiser R., Vuorela H. J., Neumann P. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol. 1984 May-Jun;6(3):399–406. [PubMed] [Google Scholar]
  8. Nagura J., Murayama B., Harada N., Suzuki K., Miyano T., Yajima M., Takeya K. Cardiovascular effects of NPK-1886, a new dihydropyridine compound with calcium entry blocking activity. Jpn J Pharmacol. 1986 Mar;40(3):399–409. doi: 10.1254/jjp.40.399. [DOI] [PubMed] [Google Scholar]
  9. Nievelstein H. M., Van Essen H., Tijssen C. M., Smits J. F., Struyker Boudier H. A. Systemic and regional hemodynamic actions of calcium entry blockers in conscious spontaneously hypertensive rats. Eur J Pharmacol. 1985 Jul 17;113(2):187–198. doi: 10.1016/0014-2999(85)90735-6. [DOI] [PubMed] [Google Scholar]
  10. Pegram B. L., Kobrin I., Sesoko S., Frohlich E. D. Nitrendipine: hemodynamic effects in conscious normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1984;6 (Suppl 7):S1016–S1023. [PubMed] [Google Scholar]
  11. Smyth H. S., Sleight P., Pickering G. W. Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res. 1969 Jan;24(1):109–121. doi: 10.1161/01.res.24.1.109. [DOI] [PubMed] [Google Scholar]
  12. Spivack C., Ocken S., Frishman W. H. Calcium antagonists. Clinical use in the treatment of systemic hypertension. Drugs. 1983 Feb;25(2):154–177. doi: 10.2165/00003495-198325020-00004. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES